MYC and colonic neoplasm: In colon cancer, the MYC oncogene is considered a key target of the wingless (WNT) pathway, and Mettl3 can promote tumor proliferation by enhancing the expression of MYC.[39] During colorectal cancer metastasis, Mettl3 can methylate pri-miR-1246.